Cetera Investment Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Cetera Investment Advisers’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$847K	Buy	11,280 +424	+4%	+$33.5K	﹤0.01%	3051
2025 Q4	$859K	Buy	10,856 +3,983	+58%	+$300K	﹤0.01%	2959
2025 Q3	$450K	Buy	+6,873	New	+$336K	﹤0.01%	3460
2024 Q2	–	Sell	-21,758	Closed	-$943K	–	3799
2024 Q1	$943K	Buy	+21,758	New	+$1.04M	﹤0.01%	2122
2021 Q1	–	Sell	-6,377	Closed	-$361K	–	1656
2020 Q4	$361K	Buy	6,377 +2,152	+51%	+$107K	0.01%	1136
2020 Q3	$200K	Sell	4,225 -220	-5%	-$12.2K	0.02%	600
2020 Q2	$262K	Buy	+4,445	New	+$247K	0.02%	508

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cetera Investment Advisers's IONS Position: Q1 2026 in Review

Cetera Investment Advisers increased its Ionis Pharmaceuticals (IONS) stake by 3.9% in Q1 2026, buying an estimated $33.5K and bringing the position to 11,280 shares worth $847K. The position accounts for ﹤0.01% of the portfolio, ranked #3051.

Cetera Investment Advisers first reported a position in IONS in Q2 2020 and has held it in 7 quarters since. The position peaked at $943K in Q1 2024. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Cetera Investment Advisers held 11,280 shares of Ionis Pharmaceuticals worth $847K as of Q1 2026.
Cetera Investment Advisers bought 424 Ionis Pharmaceuticals shares in Q1 2026, an estimated $33.5K.
Ionis Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3051 holding.
Cetera Investment Advisers first reported a position in Ionis Pharmaceuticals in Q2 2020 and has held it in 7 quarters since.
Cetera Investment Advisers's Ionis Pharmaceuticals position peaked at $943K in Q1 2024.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.